Basit Chaudhry, MD, PhD, founder of Tuple Health, discussed the feedback he's heard from practices about the Oncology Care Model and how these opinions could be used to guide potential changes.
Basit Chaudhry, MD, PhD, founder of Tuple Health, discussed the feedback he's heard from practices about the Oncology Care Model and how these opinions could be used to guide potential changes.
Transcript (slightly modified)
Based on feedback from participating practices, are there changes you think should be made to the Oncology Care Model?
Yes, I think one of the areas where we’ve gotten a lot of feedback on is data reporting requirements on both the quality measures and the clinical measures. I think it’s a fundamentally important idea in measuring quality and also the clinical data, this makes sense, but I think the burden has been significant for practices.
Medicare’s tried to improve that, particularly changing the timelines for reporting requirements, but I think moving that forward would be important, particularly prioritizing which kind of data is really going to be the key to moving value-based payment forward in oncology. I think it would reduce the kind of challenges that participants are facing.
A second area would be to continue to evolve and improve the risk adjustment model and the prediction model in OCM, to make sure that’s clinically informed as possible and really reflects the complexity of the different patients that practices take care of, I think is very important.
I think a third thing we’ve heard about quite often is just complexities that are arising around model overlap between OCM and other payment models that Medicare is putting into place, particularly around MACRA and MIPS.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More